Request Free Sample
×
Italy Ascites Market
ID: MRFR/HC/54592-HCR
200 Pages
February 2026
Italy Ascites Market Research Report: By Type (Transudative Ascites, Exudate Ascites), By Diagnosis (Ultrasound, CT Scan, Laparoscopy, Angiography), By Treatment (Surgeries) andBy End User (Hospitals & Clinics, Ambulatory Surgical Center, Diagnostic Centers)- Forecast to 2035
Industry Developments
The Italy Ascites Market has seen significant developments recently. In September 2023, Pfizer announced a collaborative agreement with Fresenius Kabi to enhance the supply chain of critical ascitic management products, aiming to address growing demands. AbbVie reported a surge in its market valuation attributed to the successful launch of innovative treatments for ascites in liver disease patients in July 2023, further emphasizing their focus on chronic liver conditions. Gilead Sciences and Roche have also made strides with their respective clinical trials, contributing positively to the market’s growth potential.Notably, in August 2023, Sanofi acquired a small biotech firm specializing in therapies for ascites-related symptoms, indicating a consolidation trend in the sector. This move is expected to leverage Sanofi's extensive distribution network across Italy. Over the past two years, market dynamics have shifted favorably due to advancements in drug formulations and regulatory support from Italian health authorities, enhancing treatment accessibility. This growth trajectory has attracted investments, further boosting research efforts by companies like AstraZeneca and Eli Lilly, which are keen on expanding their product lines targeting ascites management in Italy’s healthcare system.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 41.92(USD Million) |
| MARKET SIZE 2024 | 45.0(USD Million) |
| MARKET SIZE 2035 | 95.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.029% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Pfizer, AbbVie, Gilead Sciences, Roche, Fresenius Kabi, Boehringer Ingelheim, Celgene, Novartis, Amgen, Eli Lilly, Sanofi, Merck KGaA, Baxter International, Johnson & Johnson, AstraZeneca |
| SEGMENTS COVERED | Type, Diagnosis, Treatment, End User |
| KEY MARKET OPPORTUNITIES | Rising prevalence of liver diseases, Increased demand for diagnostic procedures, Growth in minimally invasive therapies, Advancement in pharmaceutical treatments, Expansion of healthcare infrastructure |
| KEY MARKET DYNAMICS | Rising prevalence of liver diseases, Increasing geriatric population, Advancements in diagnostic technologies, Growing healthcare expenditure, Enhanced treatment options availability |
| COUNTRIES COVERED | Italy |
Leave a Comment
FAQs
What is the expected market size of the Italy Ascites Market in 2024?
The Italy Ascites Market is expected to be valued at 45.0 USD Million in 2024.
What will be the projected growth of the Italy Ascites Market by 2035?
By 2035, the Italy Ascites Market is anticipated to reach a valuation of 95.0 USD Million.
What is the expected CAGR for the Italy Ascites Market from 2025 to 2035?
The estimated compound annual growth rate for the Italy Ascites Market from 2025 to 2035 is 7.029%.
Which segment is expected to dominate the market share in 2024?
In 2024, the Transudative Ascites segment is projected to dominate with a value of 25.0 USD Million.
What is the market size for Exudate Ascites in 2024?
The Exudate Ascites segment is expected to be valued at 20.0 USD Million in 2024.
Who are the major players in the Italy Ascites Market?
Key players in the Italy Ascites Market include Pfizer, AbbVie, Gilead Sciences, Roche, and Fresenius Kabi.
What is the forecasted market size for Transudative Ascites by 2035?
The Transudative Ascites market is forecasted to reach 53.6 USD Million by 2035.
What will be the market value of Exudate Ascites in 2035?
The Exudate Ascites segment is expected to grow to 41.4 USD Million by 2035.
What are the growth drivers for the Italy Ascites Market?
The growth drivers for the Italy Ascites Market include rising prevalence of liver diseases and advancements in treatment options.
How is the current global scenario impacting the Italy Ascites Market?
Current global factors may influence supply chains and healthcare access, impacting the growth trajectory of the Italy Ascites Market.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense